Education
About Us
Working with TipRanks
Follow Us
Puma Biotechnology (PBYI)
NASDAQ:PBYI
Total Valuation
Puma Biotechnology has a market cap or net worth of $149.33M. The enterprise value is $123.81M.
Market Cap$149.33M
Enterprise Value$123.81M
Share Statistics
Puma Biotechnology has 49,610,798 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding49,610,798
Owned by Insiders31.95%
Owned by Institutions0.04%
Financial Efficiency
Puma Biotechnology’s return on equity (ROE) is 0.33 and return on invested capital (ROIC) is 23.14%.
Return on Equity (ROE)0.33
Return on Assets (ROA)0.14
Return on Invested Capital (ROIC)23.14%
Return on Capital Employed (ROCE)0.26
Revenue Per Employee1.34M
Profits Per Employee176.03K
Employee Count172
Asset Turnover1.08
Inventory Turnover7.38
Valuation Ratios
The current PE Ratio of Puma Biotechnology is 4.90. Puma Biotechnology’s PEG ratio is 0.14.
PE Ratio4.90
PS Ratio0.76
PB Ratio1.61
Price to Fair Value1.61
Price to FCF3.82
Price to Operating Cash Flow3.81
PEG Ratio0.14
Income Statement
In the last 12 months, Puma Biotechnology had revenue of 230.47M and earned 30.28M in profits. Earnings per share was 0.62.
Revenue230.47M
Gross Profit166.06M
Operating Income30.97M
Pretax Income24.10M
Net Income30.28M
EBITDA48.08M
Earnings Per Share (EPS)0.62
Cash Flow
In the last 12 months, operating cash flow was 38.92M and capital expenditures -56.00K, giving a free cash flow of 38.86M billion.
Operating Cash Flow38.92M
Free Cash Flow38.86M
Free Cash Flow per Share0.78
Dividends & Yields
Puma Biotechnology pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.67
52-Week Price Change-40.04%
50-Day Moving Average3.10
200-Day Moving Average3.01
Relative Strength Index (RSI)50.09
Average Volume (3m)341.82K
Important Dates
Puma Biotechnology upcoming earnings date is May 8, 2025, TBA Not Confirmed.
Last Earnings DateFeb 27, 2025
Next Earnings DateMay 8, 2025
Ex-Dividend Date―
Financial Position
Puma Biotechnology as a current ratio of 1.54, with Debt / Equity ratio of 80.41%
Current Ratio1.54
Quick Ratio1.45
Debt to Market Cap0.35
Net Debt to EBITDA-0.35
Interest Coverage Ratio2.49
Taxes
In the past 12 months, Puma Biotechnology has paid -6.18M in taxes.
Income Tax-6.18M
Effective Tax Rate-0.26
Enterprise Valuation
Puma Biotechnology EV to EBITDA ratio is 2.74, with an EV/FCF ratio of 3.38.
EV to Sales0.57
EV to EBITDA2.74
EV to Free Cash Flow3.38
EV to Operating Cash Flow3.38
Balance Sheet
Puma Biotechnology has $100.97M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$26.88M billion.
Cash & Marketable Securities$100.97M
Total Debt$0.00
Net Cash-$26.88M
Net Cash Per Share-$0.54
Tangible Book Value Per Share$0.84
Margins
Gross margin is 72.06%, with operating margin of 13.44%, and net profit margin of 13.14%.
Gross Margin72.06%
Operating Margin13.44%
Pretax Margin10.46%
Net Profit Margin13.14%
EBITDA Margin20.86%
EBIT Margin15.86%
Analyst Forecast
The average price target for Puma Biotechnology is $4.33, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$4.33
Price Target Upside43.85% Upside
Analyst ConsensusHold
Analyst Count3
Revenue Growth Forecast-2.19%
EPS Growth Forecast34.91%